Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2022 Dec 31;116(3):521–529. doi: 10.1016/j.ijrobp.2022.12.035

Table 2.

Multivariable models

Variable DM PCSM OS
Hazard Ratio (95% CI), P-value

GC score 1.22 (1.09 - 1.36) <0.001* 1.23 (1.09 - 1.39) <0.001* 1.12 (1.05 - 1.20) 0.001*
Age 1.00 (0.96 - 1.04) 0.98 1.00 (0.96 - 1.04) 0.97 1.07 (1.04 - 1.10) <0.001*
Log2 pre-treatment PSA 0.99 (0.80 - 1.22) 0.91 0.96 (0.78 - 1.18) 0.68 1.01 (0.88 - 1.15) 0.90
T3-T4 vs. T1-T2 1.52 (0.89 - 2.62) 0.13 1.40 (0.80 - 2.43) 0.24 1.19 (0.85 - 1.67) 0.30
Gleason 8-10 vs. <8 2.46 (1.41 – 4.31) 0.002* 1.31 (0.73 – 2.36) 0.36 1.40 (0.99 – 1.99) 0.06

Hazard ratios of genomic classifiers were per 0.1 unit increased. Strata = original arm. Death as a competing risk for DM and PCSM.